Meet the Company
NAME: Raptor Pharmaceuticals
HEADQUARTERS: Novato, CA
STOCK PRICE AS OF 10/15/2014: $10.19
52 WEEK RANGE: $7.12-$17.72
MARKET CAPITALIZATION: $639 million
APPROVED COMPOUNDS: Cysteamine bitartrate delayed-release capsules (PROCYSBI®), FDA- approved in 2013 for treatment of nephropathic cystinosis in adults and children age 6 and older.